SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-1.1
Date Filed: 2025-08-27
Accession Number: 0001213900-25-081175
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025081175/ea025480001ex1-1_synergy.htm

Chunk 3 of 27
Word Count: 1447
Character Count: 9226

Document Content:

of its jurisdiction of incorporation. Each of the Company and its Subsidiaries has the power and authority (corporate or otherwise) to own or lease its properties and conduct its business as currently being carried on and as described in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, and is duly qualified to do business as a foreign corporation or other entity in good standing in each jurisdiction in which it owns or leases real property or in which the conduct of its business makes such qualification necessary, except where the failure to so qualify would not have or be reasonably likely to result in a material adverse effect upon the business, prospects, properties, operations, condition (financial or otherwise) or results of operations of the Company and its Subsidiaries, taken as a whole, or in its ability to perform its obligations under this Agreement (“Material Adverse Effect”).

(ii) Authorization.
The Company has the power and authority to enter into this Agreement and the Representative Warrants
and to authorize, issue and sell the Shares, the Representative Warrants and the Representative
Warrant Shares as contemplated by this Agreement and the Representative Warrants. This Agreement and
the Representative Warrants have been duly authorized by the Company, and when executed and delivered by the Company, will constitute
the valid, legal and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except
as rights to indemnity hereunder may be limited by federal or state securities laws and except as such enforceability may be limited by
bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general principles of
equity.

(iii) Contracts.
The execution, delivery and performance of this Agreement and the Representative Warrants, and
the consummation of the transactions herein contemplated will not (A) result in a breach or violation of any of the terms and provisions
of, or constitute a default under, any law, order, rule or regulation to which the Company or any Subsidiary is subject, or by which any
property or asset of the Company or any Subsidiary is bound or affected, except to the extent that the breach or violation would not reasonably
be expected to result in a Material Adverse Effect, (B) conflict with, result in any violation or breach of, or constitute a default (or
an event that with notice or lapse of time or both would become a default) under, or give to others any right of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) (a “Default Acceleration Event”) of, any
material agreement, lease, credit facility, debt, note, bond, mortgage, indenture or other instrument (the “Contracts”)
or obligation or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company
or any Subsidiary is bound or affected, except to the extent that such conflict, default, or Default Acceleration Event would not reasonably
likely to result in a Material Adverse Effect, or (C) result in a breach or violation of any of the terms and provisions of, or constitute
a default under, the Company’s articles of incorporation or by-laws.

(iv) No Violations
of Governing Documents. Neither the Company nor any of its Subsidiaries is in violation, breach or default under its certificate of
incorporation, by-laws or other equivalent organizational or governing documents.

(v) Consents.
No consents, approvals, orders, authorizations or filings are required on the part of the Company in connection with the execution, delivery
or performance of this Agreement and the Representative Warrants and the issue and sale of the Securities, except (A) the registration
under the Securities Act of the Securities, which has been effected, (B) the necessary filings and approvals from the Nasdaq to list the
Shares and the Representative Warrant Shares, (C) such consents, approvals, authorizations, registrations or qualifications as may be
required under state or foreign securities or Blue Sky laws and the rules of the Financial Industry Regulatory Authority, Inc. (“FINRA”)
in connection with the purchase and distribution of the Shares by the Underwriters, (D) such consents and approvals as have been obtained
and are in full force and effect, and (E) such consents, approvals, orders, authorizations and filings the failure of which to make or
obtain is not reasonably likely to result in a Material Adverse Effect.

(vi) Capitalization.
The Company has an authorized capitalization as set forth in the Registration Statement, the Time of Sale Disclosure Package and the Final
Prospectus. All of the issued and outstanding shares of capital stock of the Company are duly authorized and validly issued, fully paid
and nonassessable, and have been issued in compliance with all applicable securities laws, and conform in all material respects to the
description thereof in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus. All of the issued shares
of capital stock of each Subsidiary of the Company have been duly and validly authorized and issued, are fully paid and non-assessable
and, except as set forth in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus, are owned directly
or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims. Except for the issuances of options or restricted
stock in the ordinary course of business, since the respective dates as of which information is provided in the Registration Statement,
the Time of Sale Disclosure Package or the Final Prospectus, the Company has not entered into or granted any convertible or exchangeable
securities, options, warrants, agreements, contracts or other rights in existence to purchase or acquire from the Company any shares of
the capital stock of the Company. The Shares, when issued and paid for as provided herein, will be duly authorized and validly issued,
fully paid and nonassessable, will be issued in compliance with all applicable securities laws, and will be free of preemptive, registration
or similar rights, except as have been validly waived or complied with, and will conform in all material respects to the description of
the capital stock of the Company contained in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus. The
Representative Warrant Shares, when issued, paid for and delivered upon due exercise of the Representative Warrants, as applicable, will
be duly authorized and validly issued, fully paid and nonassessable, will be issued in compliance with all applicable securities laws,
and will be free of preemptive, registration or similar rights, except as have been validly waived or complied with. The Representative
Warrant Shares have been reserved for issuance. The Representative Warrants, when issued, will conform in all material respects to the
descriptions thereof set forth in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus.

(vii) Taxes.
Each of the Company and its Subsidiaries has (a) filed all foreign, federal, state and local tax returns (as hereinafter defined) required
to be filed with taxing authorities prior to the date hereof or has duly obtained extensions of time for the filing thereof and (b) paid
all taxes (as hereinafter defined) shown as due and payable on such returns that were filed and has paid all taxes imposed on or assessed
against the Company or such respective Subsidiary, except for any taxes that are currently being contested in good faith or that, if not
paid, are not reasonably expected to result in a Material Adverse Effect. The provisions for taxes payable, if any, shown on the consolidated
financial statements included in the Registration Statement, the Time of Sale Disclosure Package
and the Final Prospectus are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including
the dates of such consolidated financial statements. To the knowledge of the Company, no issues have been raised (and are currently pending)
by any taxing authority in connection with any of the returns or taxes asserted as due from the Company or its Subsidiaries, and no waivers
of statutes of limitation with respect to the returns or collection of taxes have been given by or requested from the Company or its Subsidiaries.
The term “taxes” mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales,
use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance,
stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatever,
together with any interest and any penalties, additions to tax, or additional amounts with respect thereto. The term “returns”
means all returns, declarations, reports, statements, and other documents required to be filed in respect to taxes.